Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P61278 (somatostatin)
 22,083 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In the present study the effect of somatostatin on amylase secretion was determined using in vivo cannulation and isolated acini from rat pancreas. In vivo somatostatin-14 inhibited amylase secretion in basal state and that stimulated with CCK8 and acetylcholine. Somatostatin-14 and somatostatin-28 failed to inhibit amylase secretion from isolated acini in basal state and that stimulated with CCK8 and bethanechol. Somatostatin-14 did not increase 45Ca uptake or efflux of label from acini preloaded with 45Ca. Cellular cyclic AMP levels were not significantly increased. Somatostatin-14 did not alter the synthesis of proteins in vitro, as judged by incorporation of a mixture of fifteen 14C-labeled amino acids. Somatostatin-14 stimulated phosphoprotein phosphatase in higher doses, whereas no effect was observed at lower doses. Inhibition of secretion in vivo and lack of stimulation of amylase secretion in isolated acini suggest that the somatostatin effect in vivo is mediated by an indirect effect similar to other peptides, for example, opiates and neurotensin. Stimulation of phosphoprotein phosphatase suggests that somatostatin may bind to the acinar cells and affect functions other than secretion and synthesis of enzymes.
 ...
PMID:Effect of somatostatin on amylase secretion from in vivo and in vitro rat pancreas. 242 87

Cysteamine and propionitrile cause severe duodenal ulcers with perforation within 24-48 h after a single injection in rats. These animal models were used to gain insight into the early, preulcerogenic biochemical changes in the duodenal mucosa. The results indicate that a single sc injection of cysteamine and propionitrile induced dose- and time-dependent decreases in the activity of phosphoprotein phosphatase (PPPase) in homogenate and particulate fractions of rat duodenal mucosa. The decrease in enzyme activity was detectable 4 h after the injection of the ulcerogens, it was maximal at 12 h, and hardly detectable at 24 h. No effect on the enzyme activity was found under in vitro conditions. PPPase activity in the liver was not influenced by either cysteamine or propionitrile. Furthermore, the toxic but nonulcerogenic derivative of cysteamine ethanolamine had no effect on PPPase in the duodenum. Thus, the effect of the duodenal ulcerogens on PPPase activity was indirect and organ specific, related only to the target organ (i.e., duodenal mucosa). The effect of the drugs was also selective at the level of mucosal cells: both duodenal ulcerogens depleted protein and alkaline phosphatase but not lysosomal acid phosphatase. The decrease of PPPase activity could be a general property of the duodenal ulcerogens since it is independent of their effect on endogenous somatostatin.
 ...
PMID:The influence of cysteamine and propionitrile on duodenal phosphoprotein phosphatase in rats. 289 91

Over a concentration range from 2 to 8 micrograms/ml, cyclic somatostatin inhibited cyclic AMP-dependent protein kinase and cyclic AMP binding activity in slices of mouse brain. An inverse pattern of variation was observed in the activity of phosphoprotein phosphatase. The action on kinase activity was observed in the presence of physiological concentrations of extracellular calcium, but when the concentration of calcium was increased the inhibition of kinase was not observed. These results support the idea that the protein kinase system may be involved in the action of somatostatin in the central nervous system and they are consistent with the hypothesis that somatostatin affects calcium flux.
 ...
PMID:Inhibition of cyclic AMP-dependent protein kinase by somatostatin in slices of mouse brain: dependence on extracellular calcium. 613 8

Cyclic somatostatin inhibited phosphoprotein phosphatase activity in rat liver slices, as well as a partially purified phosphoprotein phosphatase from rat liver. This change was accompanied by a concomitant decrease in cyclic AMP-dependent protein kinase. Studies in vivo showed similar trends in the variation of both enzymes.
 ...
PMID:Regulation of phosphoprotein phosphatase by somatostatin. 614 16